Development of Neurotrophic Factor Therapy for Alzheimer's Disease
- 28 September 2007
- book chapter
- Published by Wiley
- Vol. 196, 54-69
- https://doi.org/10.1002/9780470514863.ch5
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neuronsNeuron, 1995
- Ligands for EPH-Related Receptor Tyrosine Kinases that Require Membrane Attachment or Clustering for ActivityScience, 1994
- Neurotrophic factor therapy for nervous system degenerative diseasesJournal of Neurobiology, 1994
- Isolation and characterization of Bsk, a growth factor receptor‐like tyrosine kinase associated with the limbic systemJournal of Neuroscience Research, 1994
- Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's diseaseJournal of Comparative Neurology, 1993
- Cortical biopsy in Alzheimer's disease: Diagnostic accuracy and neurochemical, neuropathological, and cognitive correlationsAnnals of Neurology, 1992
- BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's diseasePublished by Elsevier ,1991
- Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factorNature, 1987
- The physiological function of nerve growth factor in the central nervous system: Comparison with the peripheryPublished by Springer Nature ,1987
- Behavioural and neurochemical effects of chronic intraventricular injections of nerve growth factor in adult rats with fimbria lesionsBehavioural Brain Research, 1985